| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $134.3M | $190.3M | $226.6M |
| YoY Revenue Growth % | -29.4% | -16.0% | — |
| Gross Profit | $15.2M | $32.1M | — |
| Gross Margin % | 11.3% | 16.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$276.9M | -$52.2M | -$49.7M |
| Operating Margin % | -80.0% | -27.4% | -21.9% |
| Net Income (GAAP) | -$289.8M | -$66.7M | -$64.8M |
| EBITDA (Normalized) | -$276.1M | -$49.9M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$14.1M | -$324.0K | $7.0M |
| Capital Expenditures (CapEx) | $1.0M | $2.9M | — |
| Free Cash Flow (FCF) | -$15.1M | -$3.2M | $7.0M |
| FCF Margin % | -11.2% | -1.7% | 3.1% |
| Return on Invested Capital (ROIC %) | -45.0% | -13.2% | — |
| Cash & Short-Term Equivalents | $6.3M | $26.1M | — |
| Total Debt (Short + Long Term) | $50.0K | $114.7M | — |
| Total Stockholders' Equity | -$63.3M | $223.7M | — |